Universal Beteiligungs und Servicegesellschaft mbH Reduces Stock Position in Teleflex Incorporated $TFX

Universal Beteiligungs und Servicegesellschaft mbH decreased its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 17.1% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 9,216 shares of the medical technology company’s stock after selling 1,902 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Teleflex were worth $1,091,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Alberta Investment Management Corp lifted its holdings in shares of Teleflex by 305.4% in the 2nd quarter. Alberta Investment Management Corp now owns 97,298 shares of the medical technology company’s stock worth $11,516,000 after acquiring an additional 73,298 shares during the last quarter. Ontario Teachers Pension Plan Board purchased a new stake in shares of Teleflex during the second quarter valued at approximately $760,000. Westwood Holdings Group Inc. boosted its stake in shares of Teleflex by 10.2% during the second quarter. Westwood Holdings Group Inc. now owns 121,534 shares of the medical technology company’s stock valued at $14,385,000 after purchasing an additional 11,261 shares during the period. Creative Planning grew its holdings in shares of Teleflex by 76.5% in the second quarter. Creative Planning now owns 10,338 shares of the medical technology company’s stock worth $1,224,000 after purchasing an additional 4,480 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in shares of Teleflex by 2.1% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 11,345 shares of the medical technology company’s stock worth $1,343,000 after purchasing an additional 231 shares during the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Up 0.8%

Shares of NYSE:TFX opened at $115.60 on Thursday. The firm has a market capitalization of $5.11 billion, a P/E ratio of 27.20, a P/E/G ratio of 1.79 and a beta of 1.05. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The stock has a 50 day moving average price of $120.69 and a 200-day moving average price of $121.24. Teleflex Incorporated has a 52-week low of $102.58 and a 52-week high of $195.24.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $3.38 by $0.29. The company had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The firm’s revenue for the quarter was up 19.4% on a year-over-year basis. During the same period in the prior year, the firm earned $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, equities research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Friday, November 14th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Friday, November 14th. Teleflex’s dividend payout ratio (DPR) is presently -18.50%.

Analyst Ratings Changes

A number of equities research analysts have issued reports on TFX shares. Truist Financial cut their price target on shares of Teleflex from $128.00 to $120.00 and set a “hold” rating on the stock in a report on Monday, November 10th. Royal Bank Of Canada dropped their target price on shares of Teleflex from $135.00 to $120.00 and set a “sector perform” rating for the company in a report on Friday, November 7th. Wells Fargo & Company reduced their price target on Teleflex from $131.00 to $114.00 and set an “equal weight” rating on the stock in a report on Friday, November 7th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research report on Tuesday. Finally, Wall Street Zen lowered Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. One investment analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and an average target price of $134.57.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.